These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4246144)

  • 1. Alteration in metabolism of acetylsalicylic acid in children with Down's syndrome: decreased plasma binding and formation of salicyluric acid.
    Ebadi MS; Kugel RB
    Pediatr Res; 1970 Mar; 4(2):187-93. PubMed ID: 4246144
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of N15 labeled uric acid in Down's syndrome.
    Coburn SP; Sirlin EM; Mertz ET
    Metabolism; 1968 Jun; 17(6):560-2. PubMed ID: 4231390
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and concentration of 5-phosphoribosyl-1-pyrophosphate in erythrocytes from patients with Down's syndrome.
    Nishida Y; Akaoka I; Nishizawa T; Maruki M; Maruki K
    Ann Rheum Dis; 1977 Jun; 36(3):261-3. PubMed ID: 141914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell size and uric acid in Down's syndrome.
    Howell A; Mason AS; Brown E; Watts RW; Chanarin I; McPherson K; Ridler MA
    Scand J Haematol; 1973; 11(2):140-7. PubMed ID: 4272676
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of salicyluric acid elimination in man.
    Levy G; Amsel LP; Elliott HC
    J Pharm Sci; 1969 Jul; 58(7):827-9. PubMed ID: 5810199
    [No Abstract]   [Full Text] [Related]  

  • 6. Amino acid profile in Down's syndrome.
    Heggarty HJ; Ball R; Smith M; Henderson MJ
    Arch Dis Child; 1996 Apr; 74(4):347-9. PubMed ID: 8669939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of physico-chemical properties and erythrocyte metabolism in children with Down's syndrome].
    Kedziora J; Hlyńczak AJ; Jeske J; Kański M
    Endokrynol Pol; 1972; 23(2):75-85. PubMed ID: 4260545
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid.
    Miners JO; Grgurinovich N; Whitehead AG; Robson RA; Birkett DJ
    Br J Clin Pharmacol; 1986 Aug; 22(2):135-42. PubMed ID: 3756063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: 5-hydroxyindoleacetic acid in Down's syndrome.
    Adlard BP; De Souza SW; Tricklebank MD
    Lancet; 1974 May; 1(7863):936. PubMed ID: 4133464
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Kinetics of salicylate metabolism.
    Gibson T; Zaphiropoulos G; Grove J; Widdop B; Berry D
    Ann Rheum Dis; 1974 Jul; 33(4):410-1. PubMed ID: 4278234
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurologic aspects of typical and atypical Down's syndrome.
    Paulson GW; Nance W; Son C
    Neurology; 1968 Mar; 18(3):305-6. PubMed ID: 4231810
    [No Abstract]   [Full Text] [Related]  

  • 12. Activities of hypoxanthine-guanine phosphoribosyltransferase and adenine phosphoribosyltransferase in erythrocytes from patients with Down's syndrome.
    Tada K; Uesaki T; Isshiki G; Oura T
    Tohoku J Exp Med; 1972 Oct; 108(2):197-8. PubMed ID: 4265623
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of plasma salicylate concentration to urinary salicylate excretion-rate.
    CUMMINGS AJ; MARTIN BK
    Nature; 1962 Sep; 195():1104-5. PubMed ID: 13882616
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal impairment in urate excretion in patients with Down's syndrome.
    Nishida Y; Akaoka I; Kobayashi M; Maruki K; Oshima Y
    J Rheumatol; 1979; 6(1):103-7. PubMed ID: 155745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catabolism of serotonin in Down's syndrome (tisomy 21).
    Kamoun P; Lafourcade G; Jerome H
    Biomedicine; 1974 Oct; 21(10):426-8. PubMed ID: 4281668
    [No Abstract]   [Full Text] [Related]  

  • 16. [Free plasma and cerebral amino acids in children with Down's syndrome].
    Abasheva GK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1068-70. PubMed ID: 6457478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdose.
    Patel DK; Ogunbona A; Notarianni LJ; Bennett PN
    Hum Exp Toxicol; 1990 Nov; 9(6):389-95. PubMed ID: 2271231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of uric acid, urea, and creatinine in Down's syndrome.
    Coburn SP; Seidenberg M; Mertz ET
    J Appl Physiol; 1967 Oct; 23(4):579-80. PubMed ID: 4228269
    [No Abstract]   [Full Text] [Related]  

  • 19. Zinc and copper in plasma and erythrocytes of Down's syndrome children.
    Purice M; Maximilian C; Dumitriu I; Ioan D
    Endocrinologie; 1988; 26(2):113-7. PubMed ID: 2970667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites.
    Ho PC; Triggs EJ; Bourne DW; Heazlewood VJ
    Br J Clin Pharmacol; 1985 May; 19(5):675-84. PubMed ID: 4005105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.